The companies amended their original agreement in January. Under the amendment, Walgreens agreed to divest up to 1,200 Rite Aid pharmacy stores, 200 more than the amount stated in the original agreement. The companies also agreed to reduce the price of each share of Rite Aid common stock from $9 per share to about $7 per share depending on the number of pharmacy stores Walgreens divests to satisfy the FTC’s complaint.
In its initial review of the agreement, the FTC expressed concerns about the deal, arguing the proposed transaction would be anticompetitive.
The companies initially agreed to an acquisition agreement in October 2015.
More articles on transactions and valuations:
76 hospital transactions and partnerships in March
This week’s 3 most-read transactions and valuations stories
Board of Governors OKs UCF, HCA hospital deal
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
